A detailed history of Tekla Capital Management LLC transactions in Xencor Inc stock. As of the latest transaction made, Tekla Capital Management LLC holds 56,675 shares of XNCR stock, worth $1.07 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
56,675
Holding current value
$1.07 Million
% of portfolio
0.06%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$24.77 - $29.9 $1.4 Million - $1.69 Million
56,675 New
56,675 $1.42 Million
Q3 2022

Nov 01, 2022

SELL
$24.62 - $32.44 $902,766 - $1.19 Million
-36,668 Reduced 15.47%
200,328 $5.21 Million
Q2 2022

Jul 29, 2022

BUY
$19.74 - $29.01 $2.45 Million - $3.61 Million
124,323 Added 110.34%
236,996 $6.49 Million
Q1 2022

May 13, 2022

BUY
$26.68 - $41.63 $3.01 Million - $4.69 Million
112,673 New
112,673 $3.01 Million
Q1 2021

May 14, 2021

SELL
$40.81 - $53.88 $6.05 Million - $7.99 Million
-148,231 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$33.73 - $46.27 $2.56 Million - $3.51 Million
75,849 Added 104.79%
148,231 $5 Million
Q1 2019

May 14, 2019

BUY
$27.85 - $38.09 $451,448 - $617,438
16,210 Added 28.86%
72,382 $2.25 Million
Q4 2018

Feb 13, 2019

BUY
$32.39 - $42.05 $1.82 Million - $2.36 Million
56,172 New
56,172 $2.03 Million
Q2 2018

Aug 13, 2018

SELL
$28.41 - $42.41 $568,200 - $848,199
-20,000 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
20,000
20,000 $422,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.13B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.